A $10.8 million product development grant was awarded to Houston-based DNAtrix Inc by the Cancer Prevention and Research Institute of Texas or CPRIT to fund its glioblastoma clinical stage program.
Breaking News
- Donald Trump Eligible for Bonus Shares Worth Over $1 Billion from Truth Social Parent Company
- TikTok Ban in US Almost Inevitable After Senate Approves Bill Forcing Parent Company to Divest Owvnership or Face Prohibition
- New Biden Administration Rule to Grant 4 Million Workers Overtime Pay; Here's What You Need to Know!
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Samsung to Implement Six-Day Work Week for Executives Slammed by Critics 'Not Effective'
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
- TikTok Ban in US Almost Inevitable After Senate Approves Bill Forcing Parent Company to Divest Owvnership or Face Prohibition
